Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BTK-IN-16 is a potential inhibitor of wild-type BTK and C481S mutants.BTK-IN-16 can be used to study various autoimmune diseases and cancers caused by BTK.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 350.00 | |
5 mg | In stock | $ 970.00 | |
10 mg | In stock | $ 1,200.00 | |
25 mg | In stock | $ 1,590.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,500.00 |
Description | BTK-IN-16 is a potential inhibitor of wild-type BTK and C481S mutants.BTK-IN-16 can be used to study various autoimmune diseases and cancers caused by BTK. |
In vivo | Studies on a mouse model (xid, X-linked immunodeficiency) have revealed the central role of BTK in B-cell BCR signal transduction, differentiation, and survival [1]. Further experiments using BTK-IN-16 on mature B cells suggest the involvement of BTK in B-cell malignancies and models of autoimmune diseases [1]. |
Molecular Weight | 282.3 |
Formula | C15H14N4O2 |
CAS No. | 2883232-92-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BTK-IN-16 2883232-92-4 Angiogenesis Tyrosine Kinase/Adaptors BTK inhibitor inhibit